smartbax in-licenses lead antibacterial compound targeting Gram-negative infections from Aicuris

Munich, Germany, Jan. 20, 2026 (GLOBE NEWSWIRE) -- smartbax, a biotech company developing next-generation antibiotics against multi-drug ...
Miami University

A26 - Targeting the periplasmic LptA protein to inhibit lipopolysaccharide transport in pathogenic Escherichia coli

Antimicrobial resistance is one of the top global public health concerns that is responsible for over one million annual deaths, according to the World Health Organization. Antimicrobial resistance is ...
Medical Xpress

Evaluating the impact of heat-inactivated bacteria on age-related inflammation

Further evidence for anti-inflammatory activity was collected from the study of the bacterial lipopolysaccharide-mediated inflammation process. Cells from YRC2606-fed animals secreted considerably ...